ADMdx

Turning images into insights

Menu
  • Home
  • About us
    • About ADMdx
    • Management team
    • Collaborations
  • Clinical trials
    • Capabilities
    • Subject inclusion
    • Enrichment and stratification
    • Detecting treatment effect
    • Data insight for planning & discovery
    • Our technology
  • Diagnostics
    • Overview
    • Dementia diagnostics
    • About dementias
    • About imaging
  • Publications
  • Contact
  • News

ADMdx to present at the Tau2020 Conference on February 12

January 22, 2020 By Dawn Matthews

ADMdx will present findings regarding the presence of tau, an abnormal protein, in Alzheimer’s patients, at the Tau2020 conference to be held in Washington DC on February 12.  This work describes the diverse burden of tau in individuals with Alzheimer’s disease, and relationships to brain atrophy, glucose metabolism, age, gender, and clinical status.

Filed Under: News

Copyright © 2021 ADM Diagnostics, Inc.